ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…
Read More »ELAB IPO
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement…
Read More »
Elevai Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today announced the closing of its previously announced…
Read More »
Shares of Elevai Labs have been approved for listing on the NASDAQ and Will Commence Trading on November 21, 2023,…
Read More »